Galc - galactosylceramidase Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 314360
Summary
Predicted to enable galactosylceramidase activity. Predicted to be involved in galactosylceramide catabolic process. Predicted to act upstream of or within myelination. Predicted to be active in lysosome. Human ortholog(s) of this gene implicated in Krabbe disease. Orthologous to human GALC (galactosylceramidase). [provided by Alliance of Genome Resources, Apr 2022]
Galc Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001005888.1 | NP_001005888.1 | galactocerebrosidase precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
galactocerebrosidase |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(9)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-136490 | Psychosine | Inhibitor | 99.9% | Unkown |
| HY-151240 | Galactosylceramide | ≥98.0% | Unkown | |
| HY-136490S | Psychosine-d5 | 99.0% | Unkown | |
| HY-E70181 | Galactosylceramidase | / | Unkown | |
| HY-112752 | Gal-C4-Chol | / | Unkown | |
| HY-136490S1 | Psychosine-d7 | 99% | Unkown | |
| HY-RS05241 | GALC Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18759 | Galc Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25246 | Galc Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service